Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 1
1998 3
1999 3
2000 1
2001 1
2003 3
2006 1
2008 3
2009 2
2010 5
2011 3
2012 1
2014 1
2015 3
2016 3
2017 1
2018 1
2019 2
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, Robieson WZ, Spindler MA, Standaert DG, Talapala S, Vaou EO, Zheng H, Facheris MF, Hauser RA. Soileau MJ, et al. Among authors: kimber te. Lancet Neurol. 2022 Dec;21(12):1099-1109. doi: 10.1016/S1474-4422(22)00400-8. Lancet Neurol. 2022. PMID: 36402160 Clinical Trial.
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Aldred J, et al. Among authors: kimber te. Neurol Ther. 2023 Dec;12(6):1937-1958. doi: 10.1007/s40120-023-00533-1. Epub 2023 Aug 26. Neurol Ther. 2023. PMID: 37632656 Free PMC article.
Brainstem lesions and gait.
Thompson PD, Kimber TE. Thompson PD, et al. Among authors: kimber te. Handb Clin Neurol. 2018;159:359-366. doi: 10.1016/B978-0-444-63916-5.00023-9. Handb Clin Neurol. 2018. PMID: 30482327 Review.
Senile chorea.
Kimber TE, Thompson PD. Kimber TE, et al. Handb Clin Neurol. 2011;100:213-7. doi: 10.1016/B978-0-444-52014-2.00013-6. Handb Clin Neurol. 2011. PMID: 21496580 Review.
Upper limb tremor.
Kimber TE, Thompson PD. Kimber TE, et al. Med J Aust. 2012 Apr 16;196(7):447-51. doi: 10.5694/mja11.11565. Med J Aust. 2012. PMID: 22509875 Review.
Updates and advances in the treatment of Parkinson disease.
Hayes MW, Fung VS, Kimber TE, O'Sullivan JD. Hayes MW, et al. Among authors: kimber te. Med J Aust. 2019 Sep;211(6):277-283. doi: 10.5694/mja2.50224. Epub 2019 Jun 16. Med J Aust. 2019. PMID: 31203580 Review.
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Aldred J, et al. Among authors: kimber te. Neurol Ther. 2023 Dec;12(6):1959-1960. doi: 10.1007/s40120-023-00554-w. Neurol Ther. 2023. PMID: 37817017 Free PMC article. No abstract available.
Current concepts in the management of Parkinson disease.
Hayes MW, Fung VS, Kimber TE, O'Sullivan JD. Hayes MW, et al. Among authors: kimber te. Med J Aust. 2010 Feb 1;192(3):144-9. doi: 10.5694/j.1326-5377.2010.tb03453.x. Med J Aust. 2010. PMID: 20121682 Review.
An update on Tourette syndrome.
Kimber TE. Kimber TE. Curr Neurol Neurosci Rep. 2010 Jul;10(4):286-91. doi: 10.1007/s11910-010-0118-2. Curr Neurol Neurosci Rep. 2010. PMID: 20446061 Review.
41 results